Invasive aspergillosis infection
Also known as: Invasive bronchopulmonary aspergillosis / Pulmonary aspergillosis / Bronchopulmonary aspergillosis / Invasive pulmonary aspergillosis
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB01263 | Posaconazole | A triazole antifungal drug that is used to treat invasive infections by Candida species and Aspergillus species in severely immunocompromised patients. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB01263 | Posaconazole | Cytochrome P450 3A4 | enzyme |
| DB01263 | Posaconazole | P-glycoprotein 1 | transporter |
| DB01263 | Posaconazole | Cytochrome P450 51 | target |
| Drug | Drug Name | Phase | Status | Count |
|---|